ANTI-VIRAL PEPTIDE NANOCOMPLEXES (APN) FOR TREATMENT OF HIV/HCV CO-INFECTION
ANTI-VIRAL PEPTIDE NANOCOMPLEXES (APN) FOR TREATMENT OF HIV/HCV CO-INFECTION
批准号:
8167881
负责人:
LARISA Y POLUEKTOVA
金额:
$22.53万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-01 至 2011-06-30
关键词:
Computer Retrieval of Information on Scientific Projects DatabaseDrug FormulationsFluorescenceFreeze DryingFundingGrantInfectionInstitutionMicellesPaclitaxelPeptidesPharmaceutical PreparationsPharmacologic SubstancePolymersPreparationPropertyPyrenesResearchResearch PersonnelResourcesScienceSourceToxic effectUnited States National Institutes of HealthViralWaterbasecopolymerimmunogenicimmunogenicitytumorwater solubility
中文摘要
这个子项目是众多研究子项目之一
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Solubilization of highly hydrophobic drugs with carriers that are non-toxic, non-immunogenic and well defined remains a major obstacle in pharmaceutical sciences. Well-defined amphiphilic di- and triblock copolymers based on poly(2-oxazolines) were prepared and used for the solubilization of Paclitaxel (PTX) and other water-insoluble drugs. Probing the polymer micelles in water with the fluorescence probe pyrene, an unusual high polar microenvironment of the probe was observed. This coincides with an extraordinary large loading capacity for PTX of 45 wt.% active drug in the formulation as well as high water solubility of the resulting formulation. Physicochemical properties of the formulations, ease of preparation and stability upon lyophilization, low toxicity and immunogenicity suggest that poly(2-oxazoline)s are promising candidates for the delivery of highly challenging drugs. Furthermore, we demonstrate that PTX is fully active and provides superior tumor inhibition as compared to the commercial micellar formulation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANTI-VIRAL PEPTIDE NANOCOMPLEXES (APN) FOR TREATMENT OF HIV/HCV CO-INFECTION
-
批准号:8360243
-
项目类别:
-
资助金额:$23.67万
-
财政年份:2011
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
IMMUNE MODULATION AND RESTORATION IN HIV-1 INFECTION
-
批准号:7959386
-
项目类别:
-
资助金额:$6.69万
-
财政年份:2009
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
SUBTYPE C HIV VACCINE TESTING IN HUMANIZED MICE
-
批准号:7719943
-
项目类别:
-
资助金额:$28.4万
-
财政年份:2008
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
SUBTYPE C HIV VACCINE TESTING IN HUMANIZED MICE
-
批准号:7609835
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2007
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
Humanized mice for Neuro AIDS
-
批准号:7472578
-
项目类别:
-
资助金额:$18.38万
-
财政年份:2007
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
Humanized mice for Neuro AIDS
-
批准号:7339210
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2007
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
SIV, IDO, and the Host Response in neuroAIDS
-
批准号:7746470
-
项目类别:
-
资助金额:$30.82万
-
财政年份:2006
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
NEURODEGENERATION AND NEURORESTITUTION IN MURINE HIV-1 ENCEPHALITIS
-
批准号:7381203
-
项目类别:
-
资助金额:$30.22万
-
财政年份:2006
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
NEURODEGENERATION/NEURORESTITUTION--HIV-1 ENCEPHALITIS
-
批准号:7170369
-
项目类别:
-
资助金额:$17.59万
-
财政年份:2005
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
NEURODEGENERATION AND NEURORESTITUTION IN MURINE HIV-1 ENCEPHALITIS
-
批准号:7011810
-
项目类别:
-
资助金额:$22.39万
-
财政年份:2004
-
负责人:LARISA Y POLUEKTOVA
-
依托单位:
海外基金